NCT01158482 Filter Initial & Long Term Evaluation After Placement and Retrieval Registry
| NCT ID | NCT01158482 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Venous Thromboembolism |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2010-06 |
| Primary Completion | 2027-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2010-06 with a primary completion date of 2027-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A prospective data registry for all patients who undergo IVC (Inferior Vena Cava) filter placement or retrieval at Stanford. Potential enrollees will already be undergoing the procedure. If patients are willing, they will be prospectively enrolled prior to the procedure. As part of the study, chart and clinical data reviews will be used to track patient progress and response to the treatment.
Eligibility Criteria
Inclusion Criteria: * Participants are adults, 18 years old or older * Participants will be undergoing a procedure to have an IVC filter placed or removed Exclusion Criteria: None
Contact & Investigator
William T Kuo MD
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT01158482 clinical trial?
This trial is open to participants of all sexes, studying Venous Thromboembolism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01158482 currently recruiting?
Yes, NCT01158482 is actively recruiting participants. Contact the research team at wkuo@stanford.edu for enrollment information.
Where is the NCT01158482 trial being conducted?
This trial is being conducted at Stanford, United States.
Who is sponsoring the NCT01158482 clinical trial?
NCT01158482 is sponsored by Stanford University. The principal investigator is William T Kuo MD at Stanford University. The trial plans to enroll 5,000 participants.